Ipca Laboratories’ Piparia (Silvassa) formulations manufacturing facility has received Voluntary Action Indicated (VAI) classification from U.S. Food and Drug Administration (USFDA). Based on this inspection, this facility is considered to be in a minimally acceptable state of compliance with regards to current good manufacturing practice (CGMP).
USFDA had conducted inspection at the said manufacturing facility from April 18, 2023 to April 26, 2023, which inspection resulted into 3 observations under USFDA Form 483.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1829.00 |
| Dr. Reddys Lab | 1287.50 |
| Cipla | 1344.65 |
| Zydus Lifesciences | 925.40 |
| Lupin | 2393.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: